(Q34199947)

31 July 2017

1 reference

title

Sarcoidosis--scientific progress and clinical challenges (English)

1 reference

31 July 2017

1 reference

Edward S Chen

1

1 reference

31 July 2017

David R Moller

series ordinal

2

1 reference

31 July 2017

language of work or name

English

0 references

publication date

12 July 2011

1 reference

Nature Reviews Rheumatology

31 July 2017

published in

1 reference

31 July 2017

volume

7

1 reference

31 July 2017

issue

8

1 reference

31 July 2017

page(s)

457-467

1 reference

https://scigraph.springernature.com/pub.10.1038/nrrheum.2011.93

31 July 2017

exact match

0 references

cites work

Statement on Sarcoidosis

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.93

Clinical characteristics of patients in a case control study of sarcoidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.93

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.93

Epidemiology of sarcoidosis: recent advances and future prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.93

Racial differences in sarcoidosis incidence: a 5-year study in a health maintenance organization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.93

Sex-specific manifestations of Löfgren's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.93

Regulation of the T cell response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.93

Predictive value of BAL cell differentials in the diagnosis of interstitial lung diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.93

Sarcoidosis--immunopathogenetic concepts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.93

Expression of IL-27 in human Th1-associated granulomatous diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.93

Reprogramming of the macrophage transcriptome in response to interferon-gamma and Mycobacterium tuberculosis: signaling roles of nitric oxide synthase-2 and phagocyte oxidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.93

Hypothesis: sarcoidosis is a STAT1-mediated disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.93

Increased interleukin-13 expression in patients with sarcoidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.93

No evidence of altered alveolar macrophage polarization, but reduced expression of TLR2, in bronchoalveolar lavage cells in sarcoidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.93

Infliximab therapy in patients with chronic sarcoidosis and pulmonary involvement

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.93

Peroxisome Proliferator–Activated Receptor γ Activity Is Deficient in Alveolar Macrophages in Pulmonary Sarcoidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.93

The immune paradox of sarcoidosis and regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.93

FoxP3+ regulatory T cells suppress early stages of granuloma formation but have little impact on sarcoidosis lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.93

Analysis of regulatory T cell associated forkhead box P3 expression in the lungs of patients with sarcoidosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.93

Inhaled vasoactive intestinal peptide exerts immunoregulatory effects in sarcoidosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.93

The anergic state in sarcoidosis is associated with diminished dendritic cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.93

Linkage between Toll-like receptor (TLR) 2 promotor and intron polymorphisms: functional effects and relevance to sarcoidosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.93

Serum amyloid A regulates granulomatous inflammation in sarcoidosis through Toll-like receptor-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.93

Cytokine networks in the regulation of inflammation and fibrosis in the lung.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.93

Immunologic response of sarcoidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.93

A vicious circle of alveolar macrophages and fibroblasts perpetuates pulmonary fibrosis via CCL18.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.93

Familial aggregation of sarcoidosis. A case-control etiologic study of sarcoidosis (ACCESS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.93

Heredity in sarcoidosis: a registry-based twin study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.93

HLA-DRB1*1101: A Significant Risk Factor for Sarcoidosis in Blacks and Whites

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.93

HLA-DR predicts the prognosis in Scandinavian patients with pulmonary sarcoidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.93

HLA-DQB1*0201: a marker for good prognosis in British and Dutch patients with sarcoidosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.93

Role of genetic polymorphisms in ACE and TNF-alpha gene in sarcoidosis: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.93

CARD15 gene mutations in sarcoidosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.93

A common haplotype of the C-C chemokine receptor 2 gene and HLA-DRB1*0301 are independent genetic risk factors for Löfgren's syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.93

CARD15/NOD2 polymorphisms are associated with severe pulmonary sarcoidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.93

Expression of receptor for advanced glycation end products in sarcoid granulomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.93

Sarcoidosis and granuloma genes: a family-based study in African-Americans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.93

Sarcoidosis is associated with a truncating splice site mutation in BTNL2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.93

The BTNL2 gene and sarcoidosis susceptibility in African Americans and Whites

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.93

Analysis of BTNL2 genetic polymorphisms in British and Dutch patients with sarcoidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.93

Genome-wide association study identifies ANXA11 as a new susceptibility locus for sarcoidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.93

Genome-wide association analysis in sarcoidosis and Crohn's disease unravels a common susceptibility locus on 10p12.2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.93

Racial and ethnic disparities in sarcoidosis: from genetics to socioeconomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.93

A case control etiologic study of sarcoidosis: environmental and occupational risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.93

Smoking-dependent reprogramming of alveolar macrophage polarization: implication for pathogenesis of chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.93

Investigation of a unique time-space cluster of sarcoidosis in firefighters

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.93

World Trade Center "sarcoid-like" granulomatous pulmonary disease in New York City fire department rescue workers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.93

"Sarcoid like" granulomatous pulmonary disease in World Trade Center disaster responders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.93

Molecular evidence for the role of mycobacteria in sarcoidosis: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.93

Mycobacterial catalase-peroxidase is a tissue antigen and target of the adaptive immune response in systemic sarcoidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.93

Role of KatG catalase-peroxidase in mycobacterial pathogenesis: countering the phagocyte oxidative burst

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.93

Transformation with katG restores isoniazid-sensitivity in Mycobacterium tuberculosis isolates resistant to a range of drug concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.93

T cell responses to mycobacterial catalase-peroxidase profile a pathogenic antigen in systemic sarcoidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.93

Cellular recognition of Mycobacterium tuberculosis ESAT-6 and KatG peptides in systemic sarcoidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.93

Multiple mycobacterial antigens are targets of the adaptive immune response in pulmonary sarcoidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.93

Quantitative analysis of mycobacterial and propionibacterial DNA in lymph nodes of Japanese and European patients with sarcoidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.93

Indigenous pulmonary Propionibacterium acnes primes the host in the development of sarcoid-like pulmonary granulomatosis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.93

Pulmonary immune responses to Propionibacterium acnes in C57BL/6 and BALB/c mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.93

Autoimmune T cell responses to antigenic peptides presented by bronchoalveolar lavage cell HLA-DR molecules in sarcoidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.93

The K veim response: still useful, still a puzzle

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.93

A randomized controlled trial of standard vs endobronchial ultrasonography-guided transbronchial needle aspiration in patients with suspected sarcoidosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.93

Corticosteroid treatment in pulmonary sarcoidosis: do serial lavage lymphocyte counts, serum angiotensin converting enzyme measurements, and gallium-67 scans help management?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.93

Magnetic resonance imaging and nuclear imaging in sarcoidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.93

Interstitial lung disease guideline: the British Thoracic Society in collaboration with the Thoracic Society of Australia and New Zealand and the Irish Thoracic Society

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.93

Steroid-sparing alternative treatments for sarcoidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.93

The use of tetracyclines for the treatment of sarcoidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.93

Treatment of chronic sarcoidosis with an azathioprine/prednisolone regimen

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.93

Treatment of CNS sarcoidosis with infliximab and mycophenolate mofetil

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.93

Successful treatment of sarcoidosis with leflunomide

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.93

Thalidomide for chronic sarcoidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.93

Treatment of corticosteroid-resistant neurosarcoidosis with a short-course cyclophosphamide regimen

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.93

Etanercept for the treatment of stage II and III progressive pulmonary sarcoidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.93

Vitamin D and sarcoidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.93

Cardiac involvement in patients with sarcoidosis: diagnostic and prognostic value of outpatient testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.93

Treatment of sarcoidosis-associated pulmonary hypertension. A two-center experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.93

Pulmonary hypertension associated with sarcoidosis: mechanisms, haemodynamics and prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.93

Lung transplantation in pulmonary fibrosis: challenging early outcomes counterbalanced by surprisingly good outcomes beyond 15 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.93

Outcome of heart transplantation in patients with sarcoid cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.93

Depression in sarcoidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.93

Quality of life, anxiety and depression in sarcoidosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.93

[Opportunistic infections and sarcoidosis]

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.93

Role of IL-18 in CD4+ T lymphocyte activation in sarcoidosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.93

Activated T cells and cytokines in bronchoalveolar lavages from patients with various lung diseases associated with eosinophilia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.93

Sarcoidosis is a Th1/Th17 multisystem disorder

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.93

Recurrent pulmonary sarcoidosis in HIV-infected patients receiving highly active antiretroviral therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.93

Restricted V alpha 2.3 gene usage by CD4+ T lymphocytes in bronchoalveolar lavage fluid from sarcoidosis patients correlates with HLA-DR3

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.93

Higher monocyte expression of TLR2 and TLR4, and enhanced pro-inflammatory synergy of TLR2 with NOD2 stimulation in sarcoidosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.93

Matrix metalloproteinases and tissue inhibitor of metalloproteinase-1 in sarcoidosis and IPF

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.93

[Epidemiology of sarcoidosis]

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.93

31 March 2020

Genetics of sarcoidosis

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.93

HLA class II amino acid epitopes as susceptibility markers of sarcoidosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.93

Severe pulmonary sarcoidosis is strongly associated with the haplotype HLA-DQB1*0602-DRB1*150101

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.93

Complement receptor 1 gene polymorphisms in sarcoidosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.93

Mycobacterial heat shock protein-induced blood T lymphocytes subsets and cytokine pattern: comparison of sarcoidosis with tuberculosis and healthy controls

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.93

Innate, antigen‐independent role for T cells in the activation of the immune system by Propionibacterium acnes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.93

Löfgren's syndrome revisited: a study of 186 patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.93

Multiplex immune serum biomarker profiling in sarcoidosis and systemic sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.93

The use of low dose methotrexate in refractory sarcoidosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.93

Efficacy of infliximab in extrapulmonary sarcoidosis: results from a randomised trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.93

Histologic diagnostic rate of cardiac sarcoidosis: evaluation of endomyocardial biopsies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.93

Characteristics and outcomes of patients with sarcoidosis listed for lung transplantation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.93

Aggressive therapy for neurosarcoidosis: long-term follow-up of 48 treated patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.93

Deficiency of a subset of T-cells with immunoregulatory properties in sarcoidosis

31 March 2020

1 reference

12 December 2020

Role of IL-15, IL-2, and their receptors in the development of T cell alveolitis in pulmonary sarcoidosis

1 reference

12 December 2020

Sarcoidosis in a patient with 5q-myelodysplasia. A possible pathogenetic link between the two diseases

1 reference

12 December 2020

Steroid-sparing effects of pentoxifylline in pulmonary sarcoidosis

1 reference

12 December 2020

M. avium binding to HLA-DR expressed alleles in silico: a model of phenotypic susceptibility to sarcoidosis

1 reference

12 December 2020

Proliferative response of peripheral blood mononuclear cells and levels of antibody to recombinant protein from Propionibacterium acnes DNA expression library in Japanese patients with sarcoidosis

1 reference

12 December 2020

Angiotensin II receptor type 1 1166 A/C and angiotensin converting enzyme I/D gene polymorphisms in a Dutch sarcoidosis cohort

1 reference

12 December 2020

Differentiation of sarcoidosis from tuberculosis using real-time PCR assay for the detection and quantification of Mycobacterium tuberculosis.

1 reference

12 December 2020

Two year prognosis of sarcoidosis: the ACCESS experience

1 reference

12 December 2020

Involvement of T cells and alterations in T cell receptors in sarcoidosis

1 reference

12 December 2020

Cardiac sarcoidosis: a pathology-focused review.

1 reference

12 December 2020

Prolonged culture for mycobacteria in mediastinal lymph nodes from patients with pulmonary sarcoidosis. A negative study

1 reference

12 December 2020

Enhanced expression of IL-12 associated with Th1 cytokine profiles in active pulmonary sarcoidosis

1 reference

12 December 2020

HLA and environmental interactions in sarcoidosis.

1 reference

12 December 2020

Spontaneous Monokine Release by Alveolar Macrophages in Chronic Sarcoidosis

1 reference

12 December 2020

Kveim antigen: what does it tell us about causation of sarcoidosis?

1 reference

12 December 2020

Association of HLA DQB1 0602 in sarcoidosis patients with small fiber neuropathy

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRRHEUM.2011.93

1 reference

Dimensions Publication ID

31 July 2017

1013662995

0 references

1 reference